Central retinal vein occlusion secondary to clomiphene treatment in a male carrier of factor V Leiden

Genet Test Mol Biomarkers. 2009 Apr;13(2):155-7. doi: 10.1089/gtmb.2008.0104.

Abstract

We report a case of a 35-year-old previously healthy man treated with clomiphene for infertility, who presented with blurred vision in his left eye due to ocular vein occlusion as documented by fluorescein angiography. The patient was heterozygous for the factor V Leiden (FV Leiden) mutation and for the 1298 A-C polymorphism of the methylene-tetrahydrofolate reductase (MTHFR) gene. He was treated with clopidogrel and is now free of symptoms. Because congenital thrombophilia is a moderate risk factor for central retinal vein occlusion and the administration of clomiphene may trigger this process, we recommend screening of young patients for FV Leiden before clomiphene treatment.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Clomiphene / therapeutic use
  • Clopidogrel
  • Eye / blood supply*
  • Factor V / genetics*
  • Fluorescein Angiography
  • Heterozygote*
  • Humans
  • Infertility, Male / drug therapy
  • Male
  • Mutation
  • Retinal Vein Occlusion / diagnosis*
  • Retinal Vein Occlusion / drug therapy
  • Retinal Vein Occlusion / etiology*
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use
  • Treatment Outcome

Substances

  • factor V Leiden
  • Clomiphene
  • Factor V
  • Clopidogrel
  • Ticlopidine